nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—CES1—Tamoxifen—pancreatic cancer	0.311	0.412	CbGbCtD
Oseltamivir—CES1—Irinotecan—pancreatic cancer	0.239	0.317	CbGbCtD
Oseltamivir—ABCC4—Fluorouracil—pancreatic cancer	0.116	0.154	CbGbCtD
Oseltamivir—ABCC4—Sunitinib—pancreatic cancer	0.0884	0.117	CbGbCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00486	0.0868	CbGpPWpGaD
Oseltamivir—NEU1—Asparagine N-linked glycosylation—FUT8—pancreatic cancer	0.00343	0.0613	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00262	0.0469	CbGpPWpGaD
Oseltamivir—NEU2—Asparagine N-linked glycosylation—FUT8—pancreatic cancer	0.0026	0.0465	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00244	0.0436	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—FGF13—pancreatic cancer	0.00213	0.0381	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00193	0.0346	CbGpPWpGaD
Oseltamivir—NEU1—Post-translational protein modification—FUT8—pancreatic cancer	0.00177	0.0317	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—RBBP8—pancreatic cancer	0.00162	0.0289	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—LY6E—pancreatic cancer	0.00159	0.0284	CbGpPWpGaD
Oseltamivir—NEU2—Post-translational protein modification—FUT8—pancreatic cancer	0.00134	0.024	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00132	0.0235	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—FGF13—pancreatic cancer	0.00115	0.0206	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.0011	0.0197	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00104	0.0187	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—FUT8—pancreatic cancer	0.000842	0.015	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—FUT8—pancreatic cancer	0.000638	0.0114	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—NFE2L2—pancreatic cancer	0.000598	0.0107	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000595	0.0106	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00059	0.0105	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—TYMS—pancreatic cancer	0.000584	0.0104	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—TGFA—pancreatic cancer	0.000571	0.0102	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—SLC2A2—pancreatic cancer	0.000558	0.00998	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000525	0.00938	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—PCSK1—pancreatic cancer	0.000514	0.00919	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—PLAU—pancreatic cancer	0.000482	0.00861	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.00047	0.00841	CbGpPWpGaD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000436	0.0078	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—HSPA1A—pancreatic cancer	0.000429	0.00767	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—RB1—pancreatic cancer	0.000396	0.00708	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—PCSK1—pancreatic cancer	0.00039	0.00697	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000368	0.00657	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000365	0.00653	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000356	0.00637	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000348	0.00622	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PRSS1—pancreatic cancer	0.000329	0.00588	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000327	0.00585	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—NFE2L2—pancreatic cancer	0.000323	0.00577	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000314	0.00561	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFA—pancreatic cancer	0.000308	0.00551	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—SHH—pancreatic cancer	0.000303	0.00542	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—SLC2A2—pancreatic cancer	0.000302	0.00539	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0003	0.00536	CbGpPWpGaD
Oseltamivir—Diarrhoea—Erlotinib—pancreatic cancer	0.000287	0.00151	CcSEcCtD
Oseltamivir—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000287	0.00151	CcSEcCtD
Oseltamivir—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000286	0.0015	CcSEcCtD
Oseltamivir—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000285	0.0015	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ARG2—pancreatic cancer	0.000285	0.0051	CbGpPWpGaD
Oseltamivir—Infection—Fluorouracil—pancreatic cancer	0.000285	0.0015	CcSEcCtD
Oseltamivir—Pain in extremity—Epirubicin—pancreatic cancer	0.000284	0.00149	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000284	0.00149	CcSEcCtD
Oseltamivir—Skin disorder—Gemcitabine—pancreatic cancer	0.000283	0.00149	CcSEcCtD
Oseltamivir—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000281	0.00148	CcSEcCtD
Oseltamivir—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000281	0.00148	CcSEcCtD
Oseltamivir—Visual impairment—Docetaxel—pancreatic cancer	0.00028	0.00148	CcSEcCtD
Oseltamivir—Dizziness—Tamoxifen—pancreatic cancer	0.00028	0.00148	CcSEcCtD
Oseltamivir—Dizziness—Erlotinib—pancreatic cancer	0.000277	0.00146	CcSEcCtD
Oseltamivir—Erythema multiforme—Docetaxel—pancreatic cancer	0.000275	0.00145	CcSEcCtD
Oseltamivir—Face oedema—Epirubicin—pancreatic cancer	0.000274	0.00144	CcSEcCtD
Oseltamivir—Eye disorder—Docetaxel—pancreatic cancer	0.000272	0.00143	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000271	0.00143	CcSEcCtD
Oseltamivir—Insomnia—Irinotecan—pancreatic cancer	0.000271	0.00142	CcSEcCtD
Oseltamivir—Cardiac disorder—Docetaxel—pancreatic cancer	0.00027	0.00142	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—GCG—pancreatic cancer	0.00027	0.00483	CbGpPWpGaD
Oseltamivir—Vomiting—Tamoxifen—pancreatic cancer	0.00027	0.00142	CcSEcCtD
Oseltamivir—Hypersensitivity—Sunitinib—pancreatic cancer	0.000268	0.00141	CcSEcCtD
Oseltamivir—Rash—Tamoxifen—pancreatic cancer	0.000267	0.00141	CcSEcCtD
Oseltamivir—Dermatitis—Tamoxifen—pancreatic cancer	0.000267	0.00141	CcSEcCtD
Oseltamivir—Vomiting—Erlotinib—pancreatic cancer	0.000267	0.0014	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000267	0.00477	CbGpPWpGaD
Oseltamivir—Headache—Tamoxifen—pancreatic cancer	0.000266	0.0014	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000265	0.0014	CcSEcCtD
Oseltamivir—Rash—Erlotinib—pancreatic cancer	0.000265	0.00139	CcSEcCtD
Oseltamivir—Dermatitis—Erlotinib—pancreatic cancer	0.000264	0.00139	CcSEcCtD
Oseltamivir—Insomnia—Gemcitabine—pancreatic cancer	0.000264	0.00139	CcSEcCtD
Oseltamivir—Dyspepsia—Irinotecan—pancreatic cancer	0.000263	0.00139	CcSEcCtD
Oseltamivir—Immune system disorder—Docetaxel—pancreatic cancer	0.000263	0.00138	CcSEcCtD
Oseltamivir—Headache—Erlotinib—pancreatic cancer	0.000263	0.00138	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000263	0.00138	CcSEcCtD
Oseltamivir—Pain in extremity—Doxorubicin—pancreatic cancer	0.000263	0.00138	CcSEcCtD
Oseltamivir—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000262	0.00138	CcSEcCtD
Oseltamivir—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000262	0.00138	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000261	0.00137	CcSEcCtD
Oseltamivir—Asthenia—Sunitinib—pancreatic cancer	0.000261	0.00137	CcSEcCtD
Oseltamivir—Arrhythmia—Docetaxel—pancreatic cancer	0.00026	0.00137	CcSEcCtD
Oseltamivir—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000259	0.00136	CcSEcCtD
Oseltamivir—Insomnia—Fluorouracil—pancreatic cancer	0.000259	0.00136	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000258	0.00136	CcSEcCtD
Oseltamivir—Fatigue—Irinotecan—pancreatic cancer	0.000258	0.00136	CcSEcCtD
Oseltamivir—Pain—Irinotecan—pancreatic cancer	0.000256	0.00135	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000256	0.00457	CbGpPWpGaD
Oseltamivir—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000256	0.00134	CcSEcCtD
Oseltamivir—Mental disorder—Docetaxel—pancreatic cancer	0.000255	0.00134	CcSEcCtD
Oseltamivir—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000254	0.00134	CcSEcCtD
Oseltamivir—Face oedema—Doxorubicin—pancreatic cancer	0.000253	0.00133	CcSEcCtD
Oseltamivir—Dyspepsia—Fluorouracil—pancreatic cancer	0.000252	0.00133	CcSEcCtD
Oseltamivir—Nausea—Tamoxifen—pancreatic cancer	0.000252	0.00133	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000252	0.00132	CcSEcCtD
Oseltamivir—Fatigue—Gemcitabine—pancreatic cancer	0.000251	0.00132	CcSEcCtD
Oseltamivir—Pain—Gemcitabine—pancreatic cancer	0.000249	0.00131	CcSEcCtD
Oseltamivir—Nausea—Erlotinib—pancreatic cancer	0.000249	0.00131	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TYMP—pancreatic cancer	0.000249	0.00445	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PRSS1—pancreatic cancer	0.000249	0.00445	CbGpPWpGaD
Oseltamivir—Diarrhoea—Sunitinib—pancreatic cancer	0.000248	0.00131	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000247	0.0013	CcSEcCtD
Oseltamivir—Feeling abnormal—Irinotecan—pancreatic cancer	0.000247	0.0013	CcSEcCtD
Oseltamivir—Asthma—Epirubicin—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Oseltamivir—Influenza—Epirubicin—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Oseltamivir—Back pain—Docetaxel—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Oseltamivir—Pain—Fluorouracil—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Oseltamivir—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000242	0.00128	CcSEcCtD
Oseltamivir—Dizziness—Sunitinib—pancreatic cancer	0.00024	0.00126	CcSEcCtD
Oseltamivir—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00024	0.00126	CcSEcCtD
Oseltamivir—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00024	0.00126	CcSEcCtD
Oseltamivir—Angina pectoris—Epirubicin—pancreatic cancer	0.000239	0.00126	CcSEcCtD
Oseltamivir—Abdominal pain—Irinotecan—pancreatic cancer	0.000236	0.00124	CcSEcCtD
Oseltamivir—Body temperature increased—Irinotecan—pancreatic cancer	0.000236	0.00124	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000236	0.00124	CcSEcCtD
Oseltamivir—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000236	0.00124	CcSEcCtD
Oseltamivir—Bronchitis—Epirubicin—pancreatic cancer	0.000236	0.00124	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—MYC—pancreatic cancer	0.000236	0.00421	CbGpPWpGaD
Oseltamivir—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000235	0.00124	CcSEcCtD
Oseltamivir—Anaemia—Docetaxel—pancreatic cancer	0.000234	0.00123	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—HSPA1A—pancreatic cancer	0.000232	0.00414	CbGpPWpGaD
Oseltamivir—Vomiting—Sunitinib—pancreatic cancer	0.000231	0.00122	CcSEcCtD
Oseltamivir—Body temperature increased—Gemcitabine—pancreatic cancer	0.00023	0.00121	CcSEcCtD
Oseltamivir—Rash—Sunitinib—pancreatic cancer	0.000229	0.00121	CcSEcCtD
Oseltamivir—Dermatitis—Sunitinib—pancreatic cancer	0.000229	0.0012	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000228	0.0012	CcSEcCtD
Oseltamivir—Urticaria—Fluorouracil—pancreatic cancer	0.000228	0.0012	CcSEcCtD
Oseltamivir—Headache—Sunitinib—pancreatic cancer	0.000228	0.0012	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—pancreatic cancer	0.000227	0.00119	CcSEcCtD
Oseltamivir—Asthma—Doxorubicin—pancreatic cancer	0.000227	0.00119	CcSEcCtD
Oseltamivir—Body temperature increased—Fluorouracil—pancreatic cancer	0.000226	0.00119	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000223	0.00398	CbGpPWpGaD
Oseltamivir—Cough—Docetaxel—pancreatic cancer	0.000221	0.00116	CcSEcCtD
Oseltamivir—Angina pectoris—Doxorubicin—pancreatic cancer	0.000221	0.00116	CcSEcCtD
Oseltamivir—Hypersensitivity—Irinotecan—pancreatic cancer	0.00022	0.00116	CcSEcCtD
Oseltamivir—Pneumonia—Epirubicin—pancreatic cancer	0.00022	0.00116	CcSEcCtD
Oseltamivir—Convulsion—Docetaxel—pancreatic cancer	0.00022	0.00116	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—pancreatic cancer	0.000219	0.00115	CcSEcCtD
Oseltamivir—Infestation—Epirubicin—pancreatic cancer	0.000219	0.00115	CcSEcCtD
Oseltamivir—Bronchitis—Doxorubicin—pancreatic cancer	0.000218	0.00115	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000217	0.00114	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ARG2—pancreatic cancer	0.000216	0.00386	CbGpPWpGaD
Oseltamivir—Arthralgia—Docetaxel—pancreatic cancer	0.000216	0.00114	CcSEcCtD
Oseltamivir—Myalgia—Docetaxel—pancreatic cancer	0.000216	0.00114	CcSEcCtD
Oseltamivir—Nausea—Sunitinib—pancreatic cancer	0.000216	0.00114	CcSEcCtD
Oseltamivir—Asthenia—Irinotecan—pancreatic cancer	0.000215	0.00113	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000214	0.00113	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—pancreatic cancer	0.000213	0.00112	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—pancreatic cancer	0.000213	0.00112	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—EGF—pancreatic cancer	0.000213	0.0038	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000211	0.00111	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000211	0.00111	CcSEcCtD
Oseltamivir—Asthenia—Gemcitabine—pancreatic cancer	0.000209	0.0011	CcSEcCtD
Oseltamivir—Confusional state—Docetaxel—pancreatic cancer	0.000209	0.0011	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000207	0.00109	CcSEcCtD
Oseltamivir—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000207	0.00109	CcSEcCtD
Oseltamivir—Epistaxis—Epirubicin—pancreatic cancer	0.000206	0.00109	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000206	0.00368	CbGpPWpGaD
Oseltamivir—Infection—Docetaxel—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—GCG—pancreatic cancer	0.000205	0.00366	CbGpPWpGaD
Oseltamivir—Diarrhoea—Irinotecan—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—pancreatic cancer	0.000204	0.00107	CcSEcCtD
Oseltamivir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000203	0.00107	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000202	0.00362	CbGpPWpGaD
Oseltamivir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000202	0.00107	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—pancreatic cancer	0.000202	0.00107	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—pancreatic cancer	0.000202	0.00107	CcSEcCtD
Oseltamivir—Skin disorder—Docetaxel—pancreatic cancer	0.000201	0.00106	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GLP1R—pancreatic cancer	0.000201	0.00359	CbGpPWpGaD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000201	0.00106	CcSEcCtD
Oseltamivir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000199	0.00105	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000198	0.00354	CbGpPWpGaD
Oseltamivir—Dizziness—Irinotecan—pancreatic cancer	0.000198	0.00104	CcSEcCtD
Oseltamivir—NEU1—Metabolism—DPYD—pancreatic cancer	0.000198	0.00353	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000197	0.00353	CbGpPWpGaD
Oseltamivir—Jaundice—Doxorubicin—pancreatic cancer	0.000197	0.00104	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000197	0.00104	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—pancreatic cancer	0.000196	0.00103	CcSEcCtD
Oseltamivir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000196	0.00103	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—SMAD4—pancreatic cancer	0.000193	0.00345	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000191	0.00101	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—pancreatic cancer	0.000191	0.001	CcSEcCtD
Oseltamivir—Vomiting—Irinotecan—pancreatic cancer	0.00019	0.001	CcSEcCtD
Oseltamivir—Sinusitis—Doxorubicin—pancreatic cancer	0.00019	0.000999	CcSEcCtD
Oseltamivir—Dizziness—Fluorouracil—pancreatic cancer	0.000189	0.000997	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—pancreatic cancer	0.000189	0.000996	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TYMP—pancreatic cancer	0.000189	0.00338	CbGpPWpGaD
Oseltamivir—Rash—Irinotecan—pancreatic cancer	0.000189	0.000993	CcSEcCtD
Oseltamivir—Dermatitis—Irinotecan—pancreatic cancer	0.000188	0.000992	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000188	0.000992	CcSEcCtD
Oseltamivir—NEU1—Metabolism—SLC2A2—pancreatic cancer	0.000188	0.00335	CbGpPWpGaD
Oseltamivir—Headache—Irinotecan—pancreatic cancer	0.000187	0.000986	CcSEcCtD
Oseltamivir—Insomnia—Docetaxel—pancreatic cancer	0.000187	0.000984	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—pancreatic cancer	0.000186	0.000977	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000186	0.00332	CbGpPWpGaD
Oseltamivir—Vomiting—Gemcitabine—pancreatic cancer	0.000185	0.000975	CcSEcCtD
Oseltamivir—Rash—Gemcitabine—pancreatic cancer	0.000184	0.000967	CcSEcCtD
Oseltamivir—Dermatitis—Gemcitabine—pancreatic cancer	0.000184	0.000966	CcSEcCtD
Oseltamivir—Eye disorder—Epirubicin—pancreatic cancer	0.000183	0.000966	CcSEcCtD
Oseltamivir—Headache—Gemcitabine—pancreatic cancer	0.000183	0.000961	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—pancreatic cancer	0.000182	0.000959	CcSEcCtD
Oseltamivir—Vomiting—Fluorouracil—pancreatic cancer	0.000182	0.000959	CcSEcCtD
Oseltamivir—Dyspepsia—Docetaxel—pancreatic cancer	0.000182	0.000958	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—pancreatic cancer	0.000182	0.000956	CcSEcCtD
Oseltamivir—Rash—Fluorouracil—pancreatic cancer	0.000181	0.000951	CcSEcCtD
Oseltamivir—Dermatitis—Fluorouracil—pancreatic cancer	0.00018	0.00095	CcSEcCtD
Oseltamivir—Headache—Fluorouracil—pancreatic cancer	0.000179	0.000945	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000179	0.0032	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000179	0.00094	CcSEcCtD
Oseltamivir—Fatigue—Docetaxel—pancreatic cancer	0.000178	0.000938	CcSEcCtD
Oseltamivir—Nausea—Irinotecan—pancreatic cancer	0.000178	0.000935	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—pancreatic cancer	0.000177	0.000933	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000177	0.000931	CcSEcCtD
Oseltamivir—Pain—Docetaxel—pancreatic cancer	0.000177	0.000931	CcSEcCtD
Oseltamivir—Arrhythmia—Epirubicin—pancreatic cancer	0.000175	0.000923	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—pancreatic cancer	0.000175	0.000921	CcSEcCtD
Oseltamivir—Nausea—Gemcitabine—pancreatic cancer	0.000173	0.000911	CcSEcCtD
Oseltamivir—Mental disorder—Epirubicin—pancreatic cancer	0.000172	0.000905	CcSEcCtD
Oseltamivir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000172	0.000904	CcSEcCtD
Oseltamivir—Feeling abnormal—Docetaxel—pancreatic cancer	0.00017	0.000897	CcSEcCtD
Oseltamivir—Nausea—Fluorouracil—pancreatic cancer	0.00017	0.000896	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—pancreatic cancer	0.00017	0.000893	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000169	0.00089	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000169	0.000887	CcSEcCtD
Oseltamivir—Back pain—Epirubicin—pancreatic cancer	0.000165	0.00087	CcSEcCtD
Oseltamivir—Immune system disorder—Doxorubicin—pancreatic cancer	0.000164	0.000864	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000164	0.000862	CcSEcCtD
Oseltamivir—Body temperature increased—Docetaxel—pancreatic cancer	0.000163	0.00086	CcSEcCtD
Oseltamivir—Abdominal pain—Docetaxel—pancreatic cancer	0.000163	0.00086	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000163	0.00292	CbGpPWpGaD
Oseltamivir—Arrhythmia—Doxorubicin—pancreatic cancer	0.000162	0.000854	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—pancreatic cancer	0.000159	0.000838	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—pancreatic cancer	0.000158	0.000831	CcSEcCtD
Oseltamivir—Agitation—Epirubicin—pancreatic cancer	0.000157	0.000827	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000156	0.00279	CbGpPWpGaD
Oseltamivir—Vertigo—Epirubicin—pancreatic cancer	0.000154	0.000808	CcSEcCtD
Oseltamivir—Back pain—Doxorubicin—pancreatic cancer	0.000153	0.000805	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—IFNA5—pancreatic cancer	0.000153	0.00273	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Docetaxel—pancreatic cancer	0.000152	0.000802	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GLP1R—pancreatic cancer	0.000152	0.00272	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—DPYD—pancreatic cancer	0.00015	0.00268	CbGpPWpGaD
Oseltamivir—Cough—Epirubicin—pancreatic cancer	0.000149	0.000785	CcSEcCtD
Oseltamivir—Asthenia—Docetaxel—pancreatic cancer	0.000148	0.000781	CcSEcCtD
Oseltamivir—Convulsion—Epirubicin—pancreatic cancer	0.000148	0.000779	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—pancreatic cancer	0.000146	0.000769	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—pancreatic cancer	0.000145	0.000766	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—pancreatic cancer	0.000145	0.000766	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—pancreatic cancer	0.000145	0.000765	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CD44—pancreatic cancer	0.000145	0.0026	CbGpPWpGaD
Oseltamivir—Anxiety—Epirubicin—pancreatic cancer	0.000145	0.000763	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000144	0.000761	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PPP2R5B—pancreatic cancer	0.000144	0.00258	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000142	0.00254	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC2A2—pancreatic cancer	0.000142	0.00254	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MMP2—pancreatic cancer	0.000142	0.00254	CbGpPWpGaD
Oseltamivir—Vertigo—Doxorubicin—pancreatic cancer	0.000142	0.000748	CcSEcCtD
Oseltamivir—Diarrhoea—Docetaxel—pancreatic cancer	0.000141	0.000745	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000141	0.00252	CbGpPWpGaD
Oseltamivir—Confusional state—Epirubicin—pancreatic cancer	0.000141	0.00074	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000141	0.00251	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000139	0.000734	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GCG—pancreatic cancer	0.000139	0.00249	CbGpPWpGaD
Oseltamivir—Infection—Epirubicin—pancreatic cancer	0.000139	0.000729	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—pancreatic cancer	0.000138	0.000726	CcSEcCtD
Oseltamivir—Convulsion—Doxorubicin—pancreatic cancer	0.000137	0.000721	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—pancreatic cancer	0.000137	0.00072	CcSEcCtD
Oseltamivir—Dizziness—Docetaxel—pancreatic cancer	0.000137	0.00072	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000137	0.000719	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000136	0.00243	CbGpPWpGaD
Oseltamivir—Skin disorder—Epirubicin—pancreatic cancer	0.000135	0.000713	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFB1—pancreatic cancer	0.000135	0.00242	CbGpPWpGaD
Oseltamivir—Myalgia—Doxorubicin—pancreatic cancer	0.000135	0.000709	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—pancreatic cancer	0.000135	0.000709	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—pancreatic cancer	0.000134	0.000706	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000134	0.000704	CcSEcCtD
Oseltamivir—Vomiting—Docetaxel—pancreatic cancer	0.000131	0.000692	CcSEcCtD
Oseltamivir—NEU1—Metabolism—STK11—pancreatic cancer	0.000131	0.00234	CbGpPWpGaD
Oseltamivir—Rash—Docetaxel—pancreatic cancer	0.00013	0.000686	CcSEcCtD
Oseltamivir—Dermatitis—Docetaxel—pancreatic cancer	0.00013	0.000686	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—pancreatic cancer	0.00013	0.000685	CcSEcCtD
Oseltamivir—Headache—Docetaxel—pancreatic cancer	0.00013	0.000682	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000129	0.000679	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—pancreatic cancer	0.000129	0.0023	CbGpPWpGaD
Oseltamivir—Infection—Doxorubicin—pancreatic cancer	0.000128	0.000675	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000127	0.000669	CcSEcCtD
Oseltamivir—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000127	0.000666	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000126	0.000665	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—pancreatic cancer	0.000126	0.000664	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—pancreatic cancer	0.000125	0.00066	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000124	0.00221	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000123	0.0022	CbGpPWpGaD
Oseltamivir—Nausea—Docetaxel—pancreatic cancer	0.000123	0.000646	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—pancreatic cancer	0.000123	0.000646	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	0.000123	0.00219	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00012	0.000634	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—pancreatic cancer	0.00012	0.000633	CcSEcCtD
Oseltamivir—Pain—Epirubicin—pancreatic cancer	0.000119	0.000628	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—pancreatic cancer	0.000118	0.00211	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB1—pancreatic cancer	0.000118	0.00211	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000118	0.000619	CcSEcCtD
Oseltamivir—Insomnia—Doxorubicin—pancreatic cancer	0.000117	0.000614	CcSEcCtD
Oseltamivir—Feeling abnormal—Epirubicin—pancreatic cancer	0.000115	0.000605	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000114	0.0006	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—pancreatic cancer	0.000114	0.000598	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000113	0.00202	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—TYMS—pancreatic cancer	0.000113	0.00201	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	0.000112	0.00201	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000111	0.000586	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—pancreatic cancer	0.000111	0.000586	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—pancreatic cancer	0.000111	0.000583	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—pancreatic cancer	0.00011	0.000581	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—pancreatic cancer	0.00011	0.00058	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—pancreatic cancer	0.00011	0.00058	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CD44—pancreatic cancer	0.00011	0.00197	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CTNNB1—pancreatic cancer	0.000109	0.00195	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000108	0.00193	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—MMP2—pancreatic cancer	0.000108	0.00193	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000107	0.00191	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000106	0.00056	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000106	0.000555	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GCG—pancreatic cancer	0.000106	0.00189	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—pancreatic cancer	0.000103	0.000541	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—pancreatic cancer	0.000103	0.00054	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000102	0.000537	CcSEcCtD
Oseltamivir—Body temperature increased—Doxorubicin—pancreatic cancer	0.000102	0.000537	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000101	0.0018	CbGpPWpGaD
Oseltamivir—Asthenia—Epirubicin—pancreatic cancer	0.0001	0.000527	CcSEcCtD
Oseltamivir—NEU2—Metabolism—STK11—pancreatic cancer	9.92e-05	0.00177	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.66e-05	0.00173	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—pancreatic cancer	9.54e-05	0.000502	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	9.54e-05	0.00171	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Doxorubicin—pancreatic cancer	9.51e-05	0.0005	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—CTNNB1—pancreatic cancer	9.44e-05	0.00169	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	9.43e-05	0.00169	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.31e-05	0.00166	CbGpPWpGaD
Oseltamivir—Asthenia—Doxorubicin—pancreatic cancer	9.26e-05	0.000487	CcSEcCtD
Oseltamivir—Dizziness—Epirubicin—pancreatic cancer	9.22e-05	0.000485	CcSEcCtD
Oseltamivir—NEU1—Metabolism—APOE—pancreatic cancer	9.16e-05	0.00164	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—pancreatic cancer	8.95e-05	0.0016	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—pancreatic cancer	8.87e-05	0.000467	CcSEcCtD
Oseltamivir—Diarrhoea—Doxorubicin—pancreatic cancer	8.83e-05	0.000465	CcSEcCtD
Oseltamivir—Rash—Epirubicin—pancreatic cancer	8.79e-05	0.000463	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—pancreatic cancer	8.79e-05	0.000462	CcSEcCtD
Oseltamivir—Headache—Epirubicin—pancreatic cancer	8.74e-05	0.00046	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.67e-05	0.00155	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CD44—pancreatic cancer	8.64e-05	0.00154	CbGpPWpGaD
Oseltamivir—Dizziness—Doxorubicin—pancreatic cancer	8.53e-05	0.000449	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TYMS—pancreatic cancer	8.53e-05	0.00153	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	8.38e-05	0.0015	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IFNA1—pancreatic cancer	8.37e-05	0.0015	CbGpPWpGaD
Oseltamivir—Nausea—Epirubicin—pancreatic cancer	8.28e-05	0.000436	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3CG—pancreatic cancer	8.26e-05	0.00148	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CTNNB1—pancreatic cancer	8.26e-05	0.00148	CbGpPWpGaD
Oseltamivir—Vomiting—Doxorubicin—pancreatic cancer	8.21e-05	0.000432	CcSEcCtD
Oseltamivir—Rash—Doxorubicin—pancreatic cancer	8.14e-05	0.000428	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—pancreatic cancer	8.13e-05	0.000428	CcSEcCtD
Oseltamivir—Headache—Doxorubicin—pancreatic cancer	8.08e-05	0.000426	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PPARG—pancreatic cancer	7.98e-05	0.00143	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IFNA2—pancreatic cancer	7.79e-05	0.00139	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—pancreatic cancer	7.67e-05	0.000403	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—pancreatic cancer	7.65e-05	0.00137	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	7.31e-05	0.00131	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFB1—pancreatic cancer	7.29e-05	0.0013	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CD—pancreatic cancer	7.27e-05	0.0013	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—APOE—pancreatic cancer	6.94e-05	0.00124	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.57e-05	0.00117	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CB—pancreatic cancer	6.33e-05	0.00113	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—pancreatic cancer	6.27e-05	0.00112	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CG—pancreatic cancer	6.26e-05	0.00112	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPARG—pancreatic cancer	6.04e-05	0.00108	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	5.86e-05	0.00105	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	5.7e-05	0.00102	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—pancreatic cancer	5.53e-05	0.000988	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CD—pancreatic cancer	5.51e-05	0.000984	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—pancreatic cancer	5.47e-05	0.000978	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	5.24e-05	0.000936	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	4.92e-05	0.000879	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EGF—pancreatic cancer	4.86e-05	0.000869	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CB—pancreatic cancer	4.8e-05	0.000858	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—pancreatic cancer	4.76e-05	0.00085	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	4.46e-05	0.000797	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	4.32e-05	0.000773	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—pancreatic cancer	4.15e-05	0.000741	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—pancreatic cancer	3.86e-05	0.00069	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	3.77e-05	0.000674	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.64e-05	0.000651	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—pancreatic cancer	3.15e-05	0.000564	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SRC—pancreatic cancer	3.02e-05	0.00054	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—pancreatic cancer	2.94e-05	0.000526	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—pancreatic cancer	2.93e-05	0.000523	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NRAS—pancreatic cancer	2.9e-05	0.000519	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB1—pancreatic cancer	2.7e-05	0.000482	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—pancreatic cancer	2.5e-05	0.000447	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—pancreatic cancer	2.39e-05	0.000427	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	2.3e-05	0.000411	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—pancreatic cancer	2.22e-05	0.000397	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—pancreatic cancer	2.12e-05	0.00038	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—pancreatic cancer	1.88e-05	0.000335	CbGpPWpGaD
